A horrible end to an organization that had great potential - Anonymous employee Transplant Genomics Employee Review

Perhaps it was doomed from the start? Launching a test for immunocompromised patients right before the COVID-19 pandemic started was horrible luck. It took a lot longer to gain traction in the marketplace, which made it difficult to ever hit the aggressive growth forecast Eurofins had for TGI. The death knell came with the Medicare reimbursement changes in April 2023 which cut the company revenue by more than half, leading to a massive layoff.